[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"paroxysmal-supraventricular-tachycardia-psvt\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:paroxysmal-supraventricular-tachycardia-psvt":39},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":12,"acronym":4,"eligibilityCriteria":13,"healthyVolunteers":10,"sex":14,"minAge":15,"maxAge":16,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":36,"locationsCount":4},"100595476",false,"NCT07032948","Safety and Efficacy Study of the First Domestically Produced FireMagic™ PreciSense™ 3D Microelectrode Ablation Catheter Therapy for Rapid Arrhythmia With Tissue Temperature Measurement Function","1\\. Inclusion Criteria\n\n1. Patient age between 18 and 75 years old, male or non-pregnant female;\n2. Confirmed diagnosis of supraventricular tachycardia or atrial fibrillation requiring catheter radiofrequency ablation surgery;\n3. Signed informed consent form approved by the ethics committee;\n4. Willingness to undergo follow-up and evaluation as required by the protocol.\n\n2\\. Exclusion Criteria Include:\n\n1. Exclusion criteria for atrial fibrillation patients:\n\n   Patients should not participate in this study if any of the following conditions apply:\n   * Left atrial size ≥50 mm, left ventricular ejection fraction ≤40%;\n   * Left atrial thrombus;\n   * History of atrial septal repair or atrial myxoma;\n   * History of cerebrovascular disease within the past 3 months (including stroke or transient ischaemic attack);\n   * Cardiovascular events within the past 3 months (including acute myocardial infarction, coronary artery intervention or bypass surgery, artificial valve replacement or repair, or atrial or ventricular incision);\n   * Acute or severe systemic infection;\n   * Severe liver or kidney disease;\n   * Significant bleeding tendency or haematological disorders;\n   * Patients with other conditions deemed inappropriate for participation in this trial by the investigators.\n2. Exclusion criteria for patients with ventricular tachycardia and supraventricular tachycardia:\n\nPatients should not participate in this study if any of the following conditions apply:\n\n* Left atrial size ≥50 mm and left ventricular ejection fraction ≤40%;\n* History of atrial septal defect repair or atrial myxoma;\n* Patients with cerebrovascular disease within the past 3 months (including stroke or transient ischaemic attack);\n* Patients with cardiovascular events within the past 3 months (including acute myocardial infarction, coronary artery intervention or bypass surgery, artificial valve replacement or repair, or atrial or ventricular incision);\n* Patients with acute or severe systemic infection;\n* Patients with severe liver or kidney disease;\n* Patients with a significant tendency to bleed or haematological disorders;\n* Patients with other conditions deemed by the investigator to be unsuitable for participation in this trial.","ALL","18 Years","75 Years",{"count":18,"type":19},300,"ESTIMATED","INTERVENTIONAL",[22],"NA","This project aims to evaluate the safety, efficacy, and cost-effectiveness of using FireMagic™ PreciSense™ 3D Microelectrode Ablation Catheter to treat rapid arrhythmias.",[25,26,27],"Rapid Arrhythmia","Atrial Fibrillation (AF)","Paroxysmal Supraventricular Tachycardia (PSVT)","NOT_YET_RECRUITING","2025-06-23",{"date":31,"type":32},"2025-06-24","ACTUAL",{"date":34,"type":19},"2025-08-31",{"date":34,"type":19},{"name":37,"class":38},"Shanghai MicroPort EP MedTech Co., Ltd.","INDUSTRY",""]